1. Home
  2. SLXN vs VEEE Comparison

SLXN vs VEEE Comparison

Compare SLXN & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • VEEE
  • Stock Information
  • Founded
  • SLXN 2008
  • VEEE 1994
  • Country
  • SLXN Israel
  • VEEE United States
  • Employees
  • SLXN N/A
  • VEEE N/A
  • Industry
  • SLXN
  • VEEE Marine Transportation
  • Sector
  • SLXN
  • VEEE Industrials
  • Exchange
  • SLXN NYSE
  • VEEE Nasdaq
  • Market Cap
  • SLXN 7.3M
  • VEEE 5.1M
  • IPO Year
  • SLXN N/A
  • VEEE 2021
  • Fundamental
  • Price
  • SLXN $11.30
  • VEEE $2.19
  • Analyst Decision
  • SLXN Strong Buy
  • VEEE
  • Analyst Count
  • SLXN 1
  • VEEE 0
  • Target Price
  • SLXN $5.00
  • VEEE N/A
  • AVG Volume (30 Days)
  • SLXN 821.0K
  • VEEE 34.5K
  • Earning Date
  • SLXN 08-21-2025
  • VEEE 08-13-2025
  • Dividend Yield
  • SLXN N/A
  • VEEE N/A
  • EPS Growth
  • SLXN N/A
  • VEEE N/A
  • EPS
  • SLXN N/A
  • VEEE N/A
  • Revenue
  • SLXN N/A
  • VEEE $12,724,465.00
  • Revenue This Year
  • SLXN N/A
  • VEEE N/A
  • Revenue Next Year
  • SLXN N/A
  • VEEE N/A
  • P/E Ratio
  • SLXN N/A
  • VEEE N/A
  • Revenue Growth
  • SLXN N/A
  • VEEE N/A
  • 52 Week Low
  • SLXN $0.58
  • VEEE $2.05
  • 52 Week High
  • SLXN $41.85
  • VEEE $9.30
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • VEEE 47.71
  • Support Level
  • SLXN N/A
  • VEEE $2.20
  • Resistance Level
  • SLXN N/A
  • VEEE $2.43
  • Average True Range (ATR)
  • SLXN 0.00
  • VEEE 0.11
  • MACD
  • SLXN 0.00
  • VEEE 0.01
  • Stochastic Oscillator
  • SLXN 0.00
  • VEEE 39.13

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.

Share on Social Networks: